Korean autonomous driving startup Rideflux has secured $13.9 million in pre-IPO funding from Atinum Investment and the Korea Development Bank. This latest round of investment brings the company’s total funding to $52.3 million. Rideflux is positioning itself to accelerate the commercialization of its autonomous trucks and aims for a listing on the KOSDAQ in the second half of 2025.
In other notable funding developments, HONESTAI, a provider of AI-driven banking-as-a-service, has raised $10 million in a round led by AAK. This startup’s platform has processed approximately 1.465 trillion KRW in loans while achieving industry-low delinquency rates, thanks to its proprietary AI risk management technology.
JOOMIDANG, an AI foodtech company, has secured $3.8 million in its Pre-Series A funding round. The startup aims to boost its revenue to $11.1 million this year, up from $1.5 million last year, by utilizing AI and data analytics to enhance food product development and distribution.
BIOCOM, operating in the healthcare sector, has completed a Series A funding round aimed at advancing its AI-powered personalized healthcare management solutions. The company reports 2.2x year-over-year growth and reached profitability in 2025 through its metabolome-based health platform.
Also, Rovolution, a subsidiary of Neuromeka, has raised $1.4 million in Pre-Series A funding. The company intends to expand its full-cycle robot manufacturing capabilities, which currently serve major clients like HD Hyundai Robotics and NAVER Labs. With an eye on breaking even in 2026, Rovolution is focused on providing end-to-end robot solutions.
Meanwhile, the construction technology startup Sankun has raised Series A funding to enhance its AI-driven decision-making platform. The platform currently serves 98 of South Korea’s top 100 construction firms, transitioning procurement processes into data-driven systems.
Another significant development comes from Sorcerics, an ambient AI startup that has received investments from NAVER D2SF. The funding will support the development of an autonomous smart home system, which is set to launch in North America in Q1 2026 via Kickstarter, targeting 48% of households equipped with smart devices.
In the biotechnology sector, HOYA Lab has garnered seed funding from C&Venture Partners and WOW Partners to advance its AI-powered CRISPR technology aimed at addressing off-target problems in gene therapy.
As the Korean startup ecosystem continues to thrive, companies are increasingly turning to artificial intelligence as a critical component of their business models. This trend is highlighted by the recent interview with BioArchers, a startup revolutionizing oral drug delivery through its innovative NanoLink™ platform technology. The platform aims to convert injectable peptide drugs like GLP-1 into once-weekly oral treatments, significantly enhancing bioavailability.
The influx of funding into these startups not only underscores the growing investor confidence in South Korea’s tech landscape but also signals a broader shift toward integrating advanced technologies across various sectors. With significant investments in areas such as autonomous driving, AI fintech, and healthcare, the future looks promising for Korean startups as they strive for global expansion and innovation.
See also
Enterprise AI Licenses Shift to Flat-Fee Models, Paving Way for Predictable Pricing in 2026
India’s NITI Aayog Launches LIPI to Break Language Barriers for 90% of Innovators
Write3BooksIn24Hours Launches TrilogyForge to Create Novels in Under 24 Hours
KOSME Allocates ₩11.5 Trillion to Transform Korea’s Startup Ecosystem by 2026
SATEC 2026: Industry Leaders to Examine AI’s Disruptive Role in Aerospace Innovation
